What a night to visit the West Wing. Thank you, @mattmight.

Here are 10 randomized trials I'd love to see (share links if they've been done!): 1. Potassium repletion to >4.0 vs 3.5 or 3.0 in hospitalized medical patients 2. Treatment vs observation for hypertensive urgency 3. Iron supplementation (likely IV) vs placebo for anemia of

A leading AI in medicine researcher and a leading biostatistician explain why we need more randomized clinical trials in AI and why these are so challenging. @nejm_AI https://t.co/Gg7lr6VibS Essential reading for those striving to bring urgently needed AI assistance into clinical

🥳Proud to be part of this RCT led by Anthony Rodgers from @georgeinstitute "A novel ..#SPC ..of telmisartan, amlodipine, and indapamide provided clinically meaningful improvements in #bloodpressure ..compared with dual combinations ..well tolerated" https://t.co/aS9T0CNKFv

You encounter a woman with HTN and hypokalemic metabolic alkalosis. First move? Renin and Aldo, Genetic testing, U chloride, Renal artery imaging, better history? The answer is always history. Huge kudos to prior @Rush_Nephrology fellow @MeloneyOliveira for making the diagnosis!

Does aldosterone affect the heart before primary aldosteronism (PA) develops? PA biomarkers linked to increased LV mass index by age 27, even w/o overt disease.Early detection could reshape treatment! @moragjyoung @markus_schlaich @RoshanAnanda2 @DrJunYang https://t.co/ySV8Xagzfv

Join Drs Mulatero and Brown as they debate #PrimaryAldosteronism detection - formal testing vs empiric treatment ⁦@TheEndoSociety⁩ #CEU now.

@hswapnil Would be interesting to make a survey to ask nephrologists (at least), if SPRINT changed the way BP is measured. And what are their limitations? #nephjc

Individualization of targets and all is fine But it’s mostly used by doctors as excuses to - not measure BP properly - escalate BP therapy properly Use RASi and thiazides in your CKD folks Don’t panic over creatinines Stop making excuses! #NephJC

ESCAPE-SALT study showed acute salt intake impaired micro vascular function in retinal vessels that maybe negated by KCl. Super intriguing results ⁦@CouncilonHTN⁩ #Hypertension24

Lots of interest in primary aldosteronism at #Hypertension24 If you enjoyed our PA session then you should also watch this seminar

Great talk by Dr Jennifer Brown that we should not call “confirmatory testing” but “aldosterone suppression testing as they are far from perfect to confirm and results are not consistent. #Hypertension24

It is a pleasure to discuss #Hypertension24 program innovation with @KChurchwellMD and Dr. Thu le Program Highlights Hypertension 2024 https://t.co/s5l9jHptvY via @YouTube @CouncilonHTN

Outstanding talk on role of aldosterone synthase inhibitors vs nsMRA and sMRA on BP by ⁦@ljlaffin⁩ #Hypertension24 ⁦@CouncilonHTN⁩ ⁦@AHAScience⁩

Grateful to @nih_nhlbi for supporting our conference!!! #Hypertension24 @AHAScience @AHAMeetings

Starting #Hypertension2024 with Dr. Harrison’s masterclass talk on the immune mechanism of hypertension. Looking forward to the discussions on this topic during the upcoming poster sessions! @endocelldoc

Opening session #Hypertension24 ⁦@AHAScience⁩ By ⁦@KChurchwellMD⁩ loaded with exciting programs. couldn’t be possible with all leaders ⁦@CouncilonHTN⁩

Huge thanks to our conference leadership for assembling an amazing program! #Hypertension24 @AHAScience @AHAMeetings @DrWanpen

Thrilled to share our latest preprint, the result of an incredible collaboration between the @Salic_Lab , @MdBreault, and @DrGaryHammer labs, alongside amazing collaborators. Honored to co-lead this with Donald Little and @TaciAMagalhaes 🧵

Hypokalemia and alkalosis syndromes (and Gordon syndrome) from @RenalFellowNtwk #Nephpearls #HTNSecrets Credit: Anthony Provenzano 👉🏼 https://t.co/gEiwJmOtsr